These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33121459)

  • 1. Low bone mineral density is a potential risk factor for symptom onset and related with hypocitraturia in urolithiasis patients: a single-center retrospective cohort study.
    Taguchi K; Hamamoto S; Okada A; Tanaka Y; Sugino T; Unno R; Kato T; Ando R; Tozawa K; Yasui T
    BMC Urol; 2020 Oct; 20(1):174. PubMed ID: 33121459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urolithiasis in the first year of life.
    Güven AG; Koyun M; Baysal YE; Akman S; Alimoglu E; Akbas H; Kabaalioglu A
    Pediatr Nephrol; 2010 Jan; 25(1):129-34. PubMed ID: 19705157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
    Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
    Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and metabolic features of urolithiasis and microlithiasis in children.
    Alpay H; Ozen A; Gokce I; Biyikli N
    Pediatr Nephrol; 2009 Nov; 24(11):2203-9. PubMed ID: 19603196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and metabolic abnormalities in preschool-age children with urolithiasis in southeast Anatolia.
    Elmacı AM; Ece A; Akın F
    J Pediatr Urol; 2014 Jun; 10(3):495-9. PubMed ID: 24314604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
    Strohmaier WL; Seilnacht J; Schubert G
    Urol Int; 2012; 88(3):294-7. PubMed ID: 22398801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
    Çakıroğlu B; Eyyupoğlu E; Hazar AI; Uyanik BS; Nuhoğlu B
    Arch Ital Urol Androl; 2016 Jul; 88(2):101-5. PubMed ID: 27377084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic risk factors and the effect of metaphylaxis in pediatric stone disease with hypocitraturia.
    Karsli O; Izol V; Aridogan IA; Borekoglu A; Satar N
    Urolithiasis; 2013 Feb; 41(1):9-13. PubMed ID: 23532417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations and etiology of renal stones in children less than 14 years age.
    Sepahi MA; Heidari A; Shajari A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):181-4. PubMed ID: 20061721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
    DeFoor WR; Jackson E; Minevich E; Caillat A; Reddy P; Sheldon C; Asplin J
    Urology; 2010 Jul; 76(1):242-5. PubMed ID: 20110113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors determining active urinary stone formation in patients with urolithiasis.
    Netelenbos JC; Zwijnenburg PJ; ter Wee PM
    Clin Nephrol; 2005 Mar; 63(3):188-92. PubMed ID: 15786819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative mineralogical analyzes of kidney stones and diagnosing metabolic disorders in female patients with calcium oxalate urolithiasis].
    Kustov AV; Moryganov MA; Strel'nikov AI; Zhuravleva NI; Airapetyan AO
    Urologiia; 2016 Feb; (1):11-15. PubMed ID: 28247696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate.
    Kaplon DM; Penniston KL; Nakada SY
    Urology; 2011 Feb; 77(2):295-8. PubMed ID: 20888032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
    Arrabal-Martin M; Poyatos-Andujar A; Cano-García Mdel C; Quesada-Charneco M; Abad-Menor F; Girón Prieto MS; de Haro Muñoz T; Arrabal-Polo MA
    Int Urol Nephrol; 2015 Mar; 47(3):445-9. PubMed ID: 25652872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of medical treatment and metabolic risk factors in children with urolithiasis.
    Gürgöze MK; Sarı MY
    Pediatr Nephrol; 2011 Jun; 26(6):933-7. PubMed ID: 21340610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic disturbances in Chinese children with urolithiasis: a single center report.
    Yang D; Tiselius HG; Lan C; Chen D; Chen K; Ou L; Liu Y; Xu S; Zeng G; Lei M; Wu W
    Urolithiasis; 2017 Jun; 45(3):285-290. PubMed ID: 27510800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.
    Arrabal-Polo MA; Arrabal-Martin M; Arias-Santiago S; Garrido-Gomez J; Poyatos-Andujar A; Zuluaga-Gomez A
    BJU Int; 2013 Apr; 111(4):622-7. PubMed ID: 22757744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Metabolic Disorders Associated with Urolithiasis in Cuban Pediatric Patients.
    Bacallao-Méndez RA; Mañalich-Comas R; Gutiérrez-García F; Madrid-Mancia CF; Lucero-Méndez C; Smith-González MJ
    MEDICC Rev; 2021 Jan; 23(1):43-48. PubMed ID: 33780422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.